He looked frail as heck in pics from the annual shareholder meeting but when he spoke you'd think he had the brain of a young man. God bless Al.
Mannkind's name is irrelevant with respect to Afrezza. The authority that comes with the Sanofi name is invaluable with respect to convincing doctors to prescribe and the consumer try Afrezza.
Great to hear stories like this. Having grown up with a T1 dad who had none of this available, I am so happy that the lives of others will be changed forever with Afrezza.
Posted by Matt Pfeffer. Check it out on Twitter. Just search Matt's name.
Advertising will initially be in diabetes magazines only as I understand it. TV will have to wait til late summer. Again, this is how I understand it.
Answered my own question. Here's an example from 2012.
The short game plan has worked quite well for - so much so that it will be their downfall. Wash, rinse, repeat can only work for so long, but many won't realize that until it's too late. I look forward to their demise. It has been way too long for even the most patient of longs.